Skip to content
Screener

Exelixis EXEL Free cash flow

Free cash flow at other companies

Eli Lilly logo
Eli LillyLLY
$7.76B+458%
Pfizer logo
PfizerPFE
$2.18B+23.0%
Kura Oncology logo
Kura OncologyKURA
-$85.98M-19.1%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$44.36M-6.3%
Immunome logo
ImmunomeIMNM
-$61.64M-8.7%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-$119M+10.5%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%

Valuation

See full
Market cap$14.25B+40.4%
Enterprise value$14.14B+39.0%
P/E16.6×-0.3×
P/S5.9×+1.3×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Calculated from Exelixis’s reported figures.

The source filing: Exelixis’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098

FAQ

What is Exelixis's free cash flow?
Exelixis (EXEL) reported free cash flow of $300.93M in Q2 2026.
How has Exelixis's free cash flow changed year-over-year?
Exelixis's free cash flow increased by 552.0% year-over-year, from $46.16M to $300.93M.
What is the long-term trend for Exelixis's free cash flow?
Over 4 years (2021 to 2025), Exelixis's free cash flow has grown at a 26.1% compound annual growth rate (CAGR), from $346.58M to $875.84M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Exelixis's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude